The future of neuroprotection in stroke

Á Chamorro, EH Lo, A Renú, K van Leyen… - Journal of Neurology …, 2021 - jnnp.bmj.com
Investigators acknowledge the limitations of rodent or non-human primate stroke models,
hundreds of putative neuroprotectants have been evaluated in preclinical models, but not …

Pericytes in microvessels: from “mural” function to brain and retina regeneration

N Caporarello, F D'Angeli, MT Cambria… - International journal of …, 2019 - mdpi.com
Pericytes are branched cells located in the wall of capillary blood vessels that are found
throughout the body, embedded within the microvascular basement membrane and …

A multi-laboratory preclinical trial in rodents to assess treatment candidates for acute ischemic stroke

PD Lyden, MA Diniz, F Bosetti, J Lamb… - Science translational …, 2023 - science.org
Human diseases may be modeled in animals to allow preclinical assessment of putative
new clinical interventions. Recent, highly publicized failures of large clinical trials called into …

Small extracellular vesicles secreted by human iPSC-derived MSC enhance angiogenesis through inhibiting STAT3-dependent autophagy in ischemic stroke

Y Xia, X Ling, G Hu, Q Zhu, J Zhang, Q Li… - Stem cell research & …, 2020 - Springer
Background Small extracellular vesicles (sEV) secreted by mesenchymal stem cells (MSC)
derived from human induced pluripotent stem cells (iPSC, iMSC-sEV) are considered to …

Cerebroprotection for acute ischemic stroke: looking ahead

PD Lyden - Stroke, 2021 - Am Heart Assoc
We search for ischemic stroke treatment knowing we have failed—intensely and often—to
translate mechanistic knowledge into treatments that alleviate our patients' functional …

Pericytes in brain injury and repair after ischemic stroke

W Cai, H Liu, J Zhao, LY Chen, J Chen, Z Lu… - Translational Stroke …, 2017 - Springer
Pericytes are functional components of the neurovascular unit (NVU). They provide support
to other NVU components and maintain normal physiological functions of the blood-brain …

Blood–brain barrier disruption, vascular impairment, and ischemia/reperfusion damage in diabetic stroke

P Venkat, M Chopp, J Chen - Journal of the American Heart …, 2017 - Am Heart Assoc
Stroke is a major cause of death and long-term disability accompanied by steep social and
medical costs. Diabetes mellitus (DM) is a chronic, lifelong, severe metabolic health problem …

Microglia and macrophages in neuroprotection, neurogenesis, and emerging therapies for stroke

SR Var, AV Shetty, AW Grande, WC Low, MC Cheeran - Cells, 2021 - mdpi.com
Stroke remains the number one cause of morbidity in the United States. Within weeks to
months after an ischemic event, there is a resolution of inflammation and evidence of …

Cell-based and pharmacological neurorestorative therapies for ischemic stroke

P Venkat, Y Shen, M Chopp, J Chen - Neuropharmacology, 2018 - Elsevier
Ischemic stroke remains one of most common causes of death and disability worldwide.
Stroke triggers a cascade of events leading to rapid neuronal damage and death …

The high cost of stroke and stroke cytoprotection research

PA Lapchak, JH Zhang - Translational stroke research, 2017 - Springer
Acute ischemic stroke is inadequately treated in the USA and worldwide due to a lengthy
history of neuroprotective drug failures in clinical trials. The majority of victims must endure …